Us Nuclear Corp Stock Performance
| UCLE Stock | USD 0.07 0.01 13.33% |
US Nuclear holds a performance score of 15 on a scale of zero to a hundred. The entity owns a Beta (Systematic Risk) of -9.38, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning US Nuclear are expected to decrease by larger amounts. On the other hand, during market turmoil, US Nuclear is expected to outperform it. Use US Nuclear Corp value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on US Nuclear Corp.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in US Nuclear Corp are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady essential indicators, US Nuclear exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 227.3 K | |
| Total Cashflows From Investing Activities | -21.4 K |
UCLE |
US Nuclear Relative Risk vs. Return Landscape
If you would invest 1.20 in US Nuclear Corp on September 27, 2024 and sell it today you would earn a total of 6.30 from holding US Nuclear Corp or generate 525.0% return on investment over 90 days. US Nuclear Corp is currently generating 10.3998% in daily expected returns and assumes 53.5488% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than UCLE, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US Nuclear Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for US Nuclear's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as US Nuclear Corp, and traders can use it to determine the average amount a US Nuclear's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1942
| Best Portfolio | Best Equity | UCLE | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 53.55 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average US Nuclear is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of US Nuclear by adding it to a well-diversified portfolio.
US Nuclear Fundamentals Growth
UCLE Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of US Nuclear, and US Nuclear fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on UCLE Pink Sheet performance.
| Return On Equity | -19.46 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.52) % | |||
| Operating Margin | (0.55) % | |||
| Current Valuation | 3.72 M | |||
| Shares Outstanding | 30.16 M | |||
| Price To Earning | (2.93) X | |||
| Price To Book | 9.53 X | |||
| Price To Sales | 1.80 X | |||
| Revenue | 2.14 M | |||
| EBITDA | (1.86 M) | |||
| Cash And Equivalents | 420.91 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.47 M | |||
| Debt To Equity | 2.06 % | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (441.03 K) | |||
| Earnings Per Share | (0.07) X | |||
| Total Asset | 2.85 M | |||
| Retained Earnings | (364 K) | |||
| Current Asset | 1.25 M | |||
| Current Liabilities | 723 K | |||
About US Nuclear Performance
By analyzing US Nuclear's fundamental ratios, stakeholders can gain valuable insights into US Nuclear's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Nuclear has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Nuclear has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
US Nuclear Corp., together with its subsidiaries, engages in the developing, manufacturing, and selling radiation detection and measuring equipment worldwide. Its products and services are used in nuclear reactor plants, universities, local and state hospitals, government agencies, and emergency medical techniciansfirst responders, as well as in airports, cargo, screening as ports and borders, and other critical infrastructure. US NUCLEAR operates under Scientific Technical Instruments classification in the United States and is traded on OTC Exchange.Things to note about US Nuclear Corp performance evaluation
Checking the ongoing alerts about US Nuclear for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for US Nuclear Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| US Nuclear Corp is way too risky over 90 days horizon | |
| US Nuclear Corp has some characteristics of a very speculative penny stock | |
| US Nuclear Corp appears to be risky and price may revert if volatility continues | |
| US Nuclear Corp currently holds 1.47 M in liabilities with Debt to Equity (D/E) ratio of 2.06, implying the company greatly relies on financing operations through barrowing. US Nuclear Corp has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist US Nuclear until it has trouble settling it off, either with new capital or with free cash flow. So, US Nuclear's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like US Nuclear Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UCLE to invest in growth at high rates of return. When we think about US Nuclear's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.14 M. Net Loss for the year was (1.88 M) with profit before overhead, payroll, taxes, and interest of 1.38 M. | |
| US Nuclear Corp currently holds about 420.91 K in cash with (441.03 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 38.0% of US Nuclear outstanding shares are owned by insiders |
- Analyzing US Nuclear's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Nuclear's stock is overvalued or undervalued compared to its peers.
- Examining US Nuclear's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US Nuclear's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Nuclear's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US Nuclear's pink sheet. These opinions can provide insight into US Nuclear's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for UCLE Pink Sheet analysis
When running US Nuclear's price analysis, check to measure US Nuclear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Nuclear is operating at the current time. Most of US Nuclear's value examination focuses on studying past and present price action to predict the probability of US Nuclear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Nuclear's price. Additionally, you may evaluate how the addition of US Nuclear to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |